Search

Your search keyword '"Naoya Kinota"' showing total 3 results
Start Over Author "Naoya Kinota" Topic medicine
3 results on '"Naoya Kinota"'

1. Successful Embolization of Collaterals from the Round Ligament Artery during Uterine Artery Embolization for Traumatic Uterine Leiomyoma Rupture: A Case Report

Author

Junichi Taniguchi, Yasukazu Kako, Mitsunari Maruyama, Hiroshi Tsubamoto, Taiki Moriyama, Atsushi Ogasawara, Naoya Kinota, Y Takimoto, Kana Hasegawa, Kaoru Kobayashi, Haruyuki Takaki, Sho Nitta, Hiroshi Kodama, Koichiro Yamakado, Kunihiro Shirai, and Yukiko Sugiyama

Subjects
medicine.medical_specialty, Uterine leiomyoma, Uterine fibroids, Round Ligament, business.industry, medicine.medical_treatment, medicine.disease, Surgery, medicine.anatomical_structure, Uterine artery embolization, medicine, Hemoperitoneum, Embolization, medicine.symptom, business, Artery
Published
2021

2. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy

Author

Motoma Kanaya, Kyohei Kudo, Takaaki Fujii, Naoya Kinota, Hirotaka Kato, and N Miyamoto

Subjects
Male, Carcinoma, Hepatocellular, Combination therapy, Organoplatinum Compounds, Radiofrequency ablation, Iodized oil, medicine.medical_treatment, Contrast Media, 030218 nuclear medicine & medical imaging, law.invention, 03 medical and health sciences, 0302 clinical medicine, law, medicine, Humans, Radiology, Nuclear Medicine and imaging, Microwaves, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Microwave ablation, Liver Neoplasms, Iodized Oil, Middle Aged, medicine.disease, Radiation therapy, Treatment Outcome, Tumor progression, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Miriplatin, Catheter Ablation, Female, business, Nuclear medicine
Abstract

To compare the technical efficacy and complications of the transarterial injection of a miriplatin-iodized oil suspension combined with radiofrequency ablation (RFA) or microwave ablation (MWA) in the treatment of small hepatocellular carcinomas (HCCs). This retrospective study included 123 HCCs in 101 patients treated with the transarterial injection of a miriplatin-iodized oil suspension and RFA (MPT-RFA) (maximum diameter: 1.5 $$\pm $$ 0.5 cm, range: 0.6–3.0 cm) and 68 HCCs in 49 patients treated with the transarterial injection of a miriplatin-iodized oil suspension and MWA (MPT-MWA) (maximum diameter: 1.6 $$\pm $$ 0.7 cm, range: 0.5–3.0 cm). Technical success was defined as the achievement of an ablative margin of at least 5 mm for each tumor. Technical success, complications, and local tumor progression were compared between the two groups. The initial technical success rate was significantly higher with MPT-MWA (94.1%) than with MPT-RFA (76.4%; P = 0.003). The number of treatment sessions per nodule was significantly lower with MPT-MWA (1.1) than with MPT-RFA (1.3) (P = 0.004). The major complication rates were similar with MPT-RFA (5.8%) and MPT-MWA (2.7%) (P = 0.391). The one-year local tumor progression rate was similar between MPT-RFA (0%) and MPT-MWA (0%) (P = 0.73). MPT-MWA may have improved therapeutic efficiency in the treatment of small HCCs.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results